Loading clinical trials...
Loading clinical trials...
Prospective Stratification of Infectious Risks in Multiple Sclerosis (InRIMS-Study)
This monocentric study is to identify factors that increase the susceptibility for infections and establish a questionnaire-based infection score that allows a prospective stratification for infectious risks in patients with multiple sclerosis (MS) (InRIMS-Study). The study will utilize a validated, MS-adapted questionnaire and infection diary from the Airway Infection Susceptibility (AWIS) study in a regularly followed, prospective cohort of MS patients. It is a nested project of the prospective observational Swiss MS Cohort (SMSC) and SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation) studies.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University Hospital Basel, Department of Neurology
Basel, Switzerland
Start Date
April 10, 2019
Primary Completion Date
December 31, 2022
Completion Date
December 31, 2023
Last Updated
April 17, 2025
298
ACTUAL participants
MS-adapted AWIS questionnaire (MS-AWIS)
OTHER
infection diary (MS-AWIS diary)
OTHER
Lead Sponsor
University Hospital, Basel, Switzerland
Collaborators
NCT06276634
NCT07225504
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06809192